Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 1
1990 1
1991 1
1995 1
1997 2
1999 2
2000 3
2001 2
2002 7
2003 5
2004 3
2005 7
2006 3
2007 4
2008 6
2009 6
2010 10
2011 13
2012 16
2013 18
2014 18
2015 19
2016 23
2017 20
2018 19
2019 19
2020 17
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

222 results
Results by year
Filters applied: . Clear all
Page 1
Muscle wasting and sarcopenia in heart failure and beyond: update 2017.
Springer J, Springer JI, Anker SD. Springer J, et al. ESC Heart Fail. 2017 Nov;4(4):492-498. doi: 10.1002/ehf2.12237. ESC Heart Fail. 2017. PMID: 29154428 Free PMC article. Review.
The prevalence of sarcopenia is increased in patients suffering from chronic heart failure. However, there are currently few therapy options. ...Other investigational drugs include selective androgen receptor modulators, growth hormone, IGF-1, compounds targeting my …
The prevalence of sarcopenia is increased in patients suffering from chronic heart failure. However, there are currently few t …
Mechanisms regulating skeletal muscle growth and atrophy.
Schiaffino S, Dyar KA, Ciciliot S, Blaauw B, Sandri M. Schiaffino S, et al. FEBS J. 2013 Sep;280(17):4294-314. doi: 10.1111/febs.12253. Epub 2013 Apr 17. FEBS J. 2013. PMID: 23517348 Free article. Review.
Skeletal muscle mass increases during postnatal development through a process of hypertrophy, i.e. enlargement of individual muscle fibers, and a similar process may be induced in adult skeletal muscle in response to contractile activity, such a
Skeletal muscle mass increases during postnatal development through a process of hypertrophy, i.e. enlargement of individual
Skeletal muscle wasting in chronic heart failure.
Suzuki T, Palus S, Springer J. Suzuki T, et al. ESC Heart Fail. 2018 Dec;5(6):1099-1107. doi: 10.1002/ehf2.12387. Epub 2018 Dec 7. ESC Heart Fail. 2018. PMID: 30548178 Free PMC article. Review.
Patients suffering from chronic heart failure (CHF) show an increased prevalence (~20% in elderly CHF patients) of loss of muscle mass and muscle function (i.e. sarcopenia) compared with healthy elderly people. ...The continuing development of new trea …
Patients suffering from chronic heart failure (CHF) show an increased prevalence (~20% in elderly CHF patients) of loss of …
Sarcopenia and Heart Failure.
Curcio F, Testa G, Liguori I, Papillo M, Flocco V, Panicara V, Galizia G, Della-Morte D, Gargiulo G, Cacciatore F, Bonaduce D, Landi F, Abete P. Curcio F, et al. Nutrients. 2020 Jan 14;12(1):211. doi: 10.3390/nu12010211. Nutrients. 2020. PMID: 31947528 Free PMC article. Review.
Sarcopenia is frequently misdiagnosed as cachexia. However, muscle wasting in HF has different pathogenetic features in sarcopenic and cachectic conditions. ...Paradoxically, sarcopenia is not associated with a sarcopenic cardiac muscle, but the cardia …
Sarcopenia is frequently misdiagnosed as cachexia. However, muscle wasting in HF has different pathogenetic features in …
Muscle type and fiber type specificity in muscle wasting.
Ciciliot S, Rossi AC, Dyar KA, Blaauw B, Schiaffino S. Ciciliot S, et al. Int J Biochem Cell Biol. 2013 Oct;45(10):2191-9. doi: 10.1016/j.biocel.2013.05.016. Epub 2013 May 21. Int J Biochem Cell Biol. 2013. PMID: 23702032 Review.
Muscle wasting occurs in a variety of conditions, including both genetic diseases, such as muscular dystrophies, and acquired disorders, ranging from muscle disuse to cancer cachexia, from heart failure to aging sarcopenia. ...This articl
Muscle wasting occurs in a variety of conditions, including both genetic diseases, such as muscular dystrophies, and acquired
Sarcopenia: A Time for Action. An SCWD Position Paper.
Bauer J, Morley JE, Schols AMWJ, Ferrucci L, Cruz-Jentoft AJ, Dent E, Baracos VE, Crawford JA, Doehner W, Heymsfield SB, Jatoi A, Kalantar-Zadeh K, Lainscak M, Landi F, Laviano A, Mancuso M, Muscaritoli M, Prado CM, Strasser F, von Haehling S, Coats AJS, Anker SD. Bauer J, et al. J Cachexia Sarcopenia Muscle. 2019 Oct;10(5):956-961. doi: 10.1002/jcsm.12483. Epub 2019 Sep 15. J Cachexia Sarcopenia Muscle. 2019. PMID: 31523937 Free PMC article. Review.
The Society of Sarcopenia, Cachexia and Wasting Disorders supports the recommendations of more recent consensus conferences, i.e. that rapid screening, such as with the SARC-F questionnaire, should be utilized with a formal diagnosis being made by measuring grip str …
The Society of Sarcopenia, Cachexia and Wasting Disorders supports the recommendations of more recent consensus conferences, i …
Muscle Atrophy: Present and Future.
Cao RY, Li J, Dai Q, Li Q, Yang J. Cao RY, et al. Adv Exp Med Biol. 2018;1088:605-624. doi: 10.1007/978-981-13-1435-3_29. Adv Exp Med Biol. 2018. PMID: 30390273 Review.
Muscle atrophy is the loss of muscle mass and strength, and it occurs in many diseases, such as cancer, AIDS (acquired immunodeficiency syndrome), congestive heart failure, COPD (chronic obstructive pulmonary disease), renal failure, and severe
Muscle atrophy is the loss of muscle mass and strength, and it occurs in many diseases, such as cancer, AIDS (acquired immunod
Muscle Wasting and Sarcopenia in Heart Failure-The Current State of Science.
Lena A, Anker MS, Springer J. Lena A, et al. Int J Mol Sci. 2020 Sep 8;21(18):6549. doi: 10.3390/ijms21186549. Int J Mol Sci. 2020. PMID: 32911600 Free PMC article. Review.
Sarcopenia is primarily characterized by skeletal muscle disturbances such as loss of muscle mass, quality, strength, and physical performance. It is commonly seen in elderly patients with chronic diseases. The prevalence of sarcopenia in chronic heart
Sarcopenia is primarily characterized by skeletal muscle disturbances such as loss of muscle mass, quality, strength, a …
Skeletal muscle-gut axis: emerging mechanisms of sarcopenia for intestinal and extra intestinal diseases.
de Sire R, Rizzatti G, Ingravalle F, Pizzoferrato M, Petito V, Lopetuso L, Graziani C, de Sire A, Mentella MC, Mele MC, Gasbarrini A, Scaldaferri F. de Sire R, et al. Minerva Gastroenterol Dietol. 2018 Dec;64(4):351-362. doi: 10.23736/S1121-421X.18.02511-4. Epub 2018 Jul 18. Minerva Gastroenterol Dietol. 2018. PMID: 30016852 Review.
Sarcopenia and cachexia represent two conditions of reduction of muscle mass, sharing several elements involved in their pathogenesis, such as systemic inflammation, impaired muscle protein synthesis, increased muscle apoptosis, mitochondrial dysfuncti …
Sarcopenia and cachexia represent two conditions of reduction of muscle mass, sharing several elements involved in their patho …
Protein acetylation in skeletal muscle mitochondria is involved in impaired fatty acid oxidation and exercise intolerance in heart failure.
Tsuda M, Fukushima A, Matsumoto J, Takada S, Kakutani N, Nambu H, Yamanashi K, Furihata T, Yokota T, Okita K, Kinugawa S, Anzai T. Tsuda M, et al. J Cachexia Sarcopenia Muscle. 2018 Oct;9(5):844-859. doi: 10.1002/jcsm.12322. Epub 2018 Aug 30. J Cachexia Sarcopenia Muscle. 2018. PMID: 30168279 Free PMC article.
BACKGROUND: Exercise intolerance is a common clinical feature and is linked to poor prognosis in patients with heart failure (HF). Skeletal muscle dysfunction, including impaired energy metabolism in the skeletal muscle, is suspected to p …
BACKGROUND: Exercise intolerance is a common clinical feature and is linked to poor prognosis in patients with heart failure ( …
222 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page